Clinical Trial Update: Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Gardasil evaluating prevention of cervical cancer and genital warts; the study has been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Genital Warts

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cervical Cancer, Genital Warts | Phase 3 | Status: COMPLETED | Results posted: 2009-11-26